- Home
- AORT
AORT
Artivion Inc.
as of 03-20-2026 3:55pm EST
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | KENNESAW |
| Market Cap: | 2.1B | IPO Year: | 1996 |
| Target Price: | $48.76 | AVG Volume (30 days): | 344.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | semi-annual |
| EPS: | 0.21 | EPS Growth: | 165.62 |
| 52 Week Low/High: | $21.97 - $48.25 | Next Earning Date: | 05-04-2026 |
| Revenue: | $298,836,000 | Revenue Growth: | 18.01% |
| Revenue Growth (this year): | 14.2% | Revenue Growth (next year): | 11.17% |
| P/E Ratio: | 173.52 | Index: | N/A |
| Free Cash Flow: | 839.0K | FCF Growth: | -92.41% |
AI-Powered AORT Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Artivion Inc. (AORT)
SVP, General Counsel
Avg Cost/Share
$38.00
Shares
8,962
Total Value
$340,556.00
Owned After
185,095
SEC Form 4
SVP, Clinical & MD Affair
Avg Cost/Share
$37.78
Shares
2,149
Total Value
$81,179.76
Owned After
60,097
SEC Form 4
VP, Chief Accounting Officer
Avg Cost/Share
$37.78
Shares
901
Total Value
$34,035.82
Owned After
139,088
SEC Form 4
SVP, General Counsel
Avg Cost/Share
$37.78
Shares
3,843
Total Value
$145,171.63
Owned After
185,095
SEC Form 4
President & CEO
Avg Cost/Share
$37.78
Shares
17,887
Total Value
$675,692.16
Owned After
947,275
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$37.78
Shares
4,573
Total Value
$172,747.82
Owned After
230,794
SEC Form 4
EVP, COO, CFO & Treasurer
Avg Cost/Share
$37.78
Shares
6,316
Total Value
$238,590.69
Owned After
210,827
SEC Form 4
SVP, Clinical & MD Affair
Avg Cost/Share
$38.02
Shares
1,513
Total Value
$57,531.67
Owned After
60,097
SEC Form 4
VP, Chief Accounting Officer
Avg Cost/Share
$38.02
Shares
641
Total Value
$24,373.96
Owned After
139,088
SEC Form 4
SVP, General Counsel
Avg Cost/Share
$38.02
Shares
2,183
Total Value
$83,008.36
Owned After
185,095
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Holloway Jean F | AORT | SVP, General Counsel | Mar 4, 2026 | Sell | $38.00 | 8,962 | $340,556.00 | 185,095 | |
| Stanton Marshall S. | AORT | SVP, Clinical & MD Affair | Mar 3, 2026 | Sell | $37.78 | 2,149 | $81,179.76 | 60,097 | |
| Horton Amy | AORT | VP, Chief Accounting Officer | Mar 3, 2026 | Sell | $37.78 | 901 | $34,035.82 | 139,088 | |
| Holloway Jean F | AORT | SVP, General Counsel | Mar 3, 2026 | Sell | $37.78 | 3,843 | $145,171.63 | 185,095 | |
| Mackin James P | AORT | President & CEO | Mar 3, 2026 | Sell | $37.78 | 17,887 | $675,692.16 | 947,275 | |
| Davis John E | AORT | Chief Commercial Officer | Mar 3, 2026 | Sell | $37.78 | 4,573 | $172,747.82 | 230,794 | |
| Berry Lance A | AORT | EVP, COO, CFO & Treasurer | Mar 3, 2026 | Sell | $37.78 | 6,316 | $238,590.69 | 210,827 | |
| Stanton Marshall S. | AORT | SVP, Clinical & MD Affair | Mar 2, 2026 | Sell | $38.02 | 1,513 | $57,531.67 | 60,097 | |
| Horton Amy | AORT | VP, Chief Accounting Officer | Mar 2, 2026 | Sell | $38.02 | 641 | $24,373.96 | 139,088 | |
| Holloway Jean F | AORT | SVP, General Counsel | Mar 2, 2026 | Sell | $38.02 | 2,183 | $83,008.36 | 185,095 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 12, 2026 · 100% conf.
Q4 2025 Earnings
8-K BUYFeb 12, 2026 · 100% conf.
1D
+9.40%
$44.47
Act: -9.96%
5D
+10.62%
$44.97
Act: -5.71%
20D
+13.51%
$46.14
Act: -10.48%
aort-202602120000784199FALSE00007841992026-02-122026-02-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 12, 2026
ARTIVION, INC.
(Exact name of registrant as specified in its charter)
Delaware1-1316559-2417093 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
1655 Roberts Boulevard, N.W., Kennesaw, Georgia 30144 (Address of principal executive office)(Zip Code)
Registrant’s telephone number, including area code: (770) 419-3355
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueAORTNYSE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On February 12, 2026, Artivion, Inc. (“Artivion”) issued a press release announcing its financial results for the fourth quarter ended December 31, 2025. Artivion hereby incorporates by reference herein the information set forth in its press release dated February 12, 2026, a copy of which is attached hereto as Exhibit 99.1. Except as otherwise provided in the press release, the press release speaks only as of the date of such press release and it shall not create any implication that the affairs of Artivion have continued unchanged since such date. The information provided pursuant to this Item 2.02 is to be considered “furnished” pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of Artivion’s reports or filings with the Securities and Exchange Commission, whether made before or after the date hereof, except as expressly set forth by specific reference in such report or filing. Except for the historical information contained in this report, the statements made by Artivion are forward-looking statements that involve risks and uncertainties. All such statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Artivion’s future financial performance could differ significantly from the expectations of management and from results expressed or implied in the press release. Please refer to the last paragraph of the text portion of the press release for further discussion about forward-looking statements. For further information on risk factors, please refer to “Risk Factors” contained in Artivion’s most recently filed Form 10-K and its subsequent filings with the Securities and Exchange Commission, as well as in the press release attached as Exhibit 99.1 hereto. Artivion disclaims any obligation or duty to update or modify these forward-looking statements. Item 9.01 Financial Statements and Exhibits. (d)Exhibits.
Exhibit NumberDescription 99.1* Press Release dated February 12, 2026.
104Inline XBRL for the cover page of this Current Report on Form 8-K.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Artivion, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 12, 2026
ARTIVION, INC.
By:/s/ Lance A. Berry Name:Lance A. Berry Title:Executive Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer
-3-
2025 Q3 Q3 2025 Earnings
8-K Nov 6, 2025
Q3 2025 Earnings
8-KNov 6, 2025
aort-202511060000784199FALSE00007841992025-11-062025-11-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 6, 2025
ARTIVION, INC.
(Exact name of registrant as specified in its charter)
Delaware1-1316559-2417093 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
1655 Roberts Boulevard, N.W., Kennesaw, Georgia 30144 (Address of principal executive office)(Zip Code)
Registrant’s telephone number, including area code: (770) 419-3355
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueAORTNYSE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On November 6, 2025, Artivion, Inc. (“Artivion”) issued a press release announcing its financial results for the third quarter ended September 30, 2025. Artivion hereby incorporates by reference herein the information set forth in its press release dated November 6, 2025, a copy of which is attached hereto as Exhibit 99.1. Except as otherwise provided in the press release, the press release speaks only as of the date of such press release and it shall not create any implication that the affairs of Artivion have continued unchanged since such date. The information provided pursuant to this Item 2.02 is to be considered “furnished” pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of Artivion’s reports or filings with the Securities and Exchange Commission, whether made before or after the date hereof, except as expressly set forth by specific reference in such report or filing. Except for the historical information contained in this report, the statements made by Artivion are forward-looking statements that involve risks and uncertainties. All such statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Artivion’s future financial performance could differ significantly from the expectations of management and from results expressed or implied in the press release. Please refer to the last paragraph of the text portion of the press release for further discussion about forward-looking statements. For further information on risk factors, please refer to “Risk Factors” contained in Artivion’s most recently filed Form 10-K and its subsequent filings with the Securities and Exchange Commission, as well as in the press release attached as Exhibit 99.1 hereto. Artivion disclaims any obligation or duty to update or modify these forward-looking statements. Item 9.01 Financial Statements and Exhibits. (d)Exhibits.
Exhibit NumberDescription 99.1 Press Release dated November 6, 2025.
104Inline XBRL for the cover page of this Current Report on Form 8-K.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Artivion, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 6, 2025
ARTIVION, INC.
By:/s/ Lance A. Berry Name:Lance A. Berry Title:Executive Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer
-3-
2025 Q2 Q2 2025 Earnings
8-K Aug 7, 2025
Q2 2025 Earnings
8-KAug 7, 2025
aort-202508070000784199FALSE00007841992025-08-072025-08-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 7, 2025
ARTIVION, INC.
(Exact name of registrant as specified in its charter)
Delaware1-1316559-2417093 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
1655 Roberts Boulevard, N.W., Kennesaw, Georgia 30144 (Address of principal executive office)(Zip Code)
Registrant’s telephone number, including area code: (770) 419-3355
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueAORTNYSE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On August 7, 2025, Artivion, Inc. (“Artivion”) issued a press release announcing its financial results for the second quarter ended June 30, 2025. Artivion hereby incorporates by reference herein the information set forth in its press release dated August 7, 2025, a copy of which is attached hereto as Exhibit 99.1. Except as otherwise provided in the press release, the press release speaks only as of the date of such press release and it shall not create any implication that the affairs of Artivion have continued unchanged since such date. The information provided pursuant to this Item 2.02 is to be considered “furnished” pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of Artivion’s reports or filings with the Securities and Exchange Commission, whether made before or after the date hereof, except as expressly set forth by specific reference in such report or filing. Except for the historical information contained in this report, the statements made by Artivion are forward-looking statements that involve risks and uncertainties. All such statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Artivion’s future financial performance could differ significantly from the expectations of management and from results expressed or implied in the press release. Please refer to the last paragraph of the text portion of the press release for further discussion about forward-looking statements. For further information on risk factors, please refer to “Risk Factors” contained in Artivion’s most recently filed Form 10-K and its subsequent filings with the Securities and Exchange Commission, as well as in the press release attached as Exhibit 99.1 hereto. Artivion disclaims any obligation or duty to update or modify these forward-looking statements. Item 9.01(d) Exhibits (d)Exhibits.
Exhibit NumberDescription 99.1* Press Release dated August 7, 2025.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*Furnished herewith, not filed. -2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Artivion, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 7, 2025
ARTIVION, INC.
By:/s/ Lance A. Berry Name:Lance A. Berry Title:Chief Financial Officer and Executive Vice President, Finance
-3-
Compare AORT vs Leading Stocks
See how AORT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AORT Artivion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.